Particles that deliver vaccines directly to mucosal surfaces could defend against many infectious diseases.
Many viruses and bacteria infect humans through mucosal surfaces, such as those in the lungs, gastrointestinal tract and reproductive tract. To help fight these pathogens, scientists are working on vaccines that can establish a front line of defense at mucosal surfaces.
Vaccines can be delivered to the lungs via an aerosol spray, but the lungs often clear away the vaccine before it can provoke an immune response. To overcome that, MIT engineers have developed a new type of nanoparticle that protects the vaccine long enough to generate a strong immune response — not only in the lungs, but also in mucosal surfaces far from the vaccination site, such as the gastrointestinal and reproductive tracts.
Such vaccines could help protect against influenza and other respiratory viruses, or prevent sexually transmitted diseases such as HIV, herpes simplex virus and human papilloma virus, says Darrell Irvine, an MIT professor of materials science and engineering and biological engineering and the leader of the research team. He is also exploring use of the particles to deliver cancer vaccines.
“This is a good example of a project where the same technology can be applied in cancer and in infectious disease. It’s a platform technology to deliver a vaccine of interest,” says Irvine, who is a member of MIT’s Koch Institute for Integrative Cancer Research and the Ragon Institute of Massachusetts General Hospital, MIT and Harvard University.
Irvine and colleagues describe the nanoparticle vaccine in the Sept. 25 issue of Science Translational Medicine. Lead authors of the paper are recent PhD recipient Adrienne Li and former MIT postdoc James Moon.
Sturdier vaccines
Only a handful of mucosal vaccines have been approved for human use; the best-known example is the Sabin polio vaccine, which is given orally and absorbed in the digestive tract. There is also a flu vaccine delivered by nasal spray, and mucosal vaccines against cholera, rotavirus and typhoid fever.
To create better ways of delivering such vaccines, Irvine and his colleagues built upon a nanoparticle they developed two years ago. The protein fragments that make up the vaccine are encased in a sphere made of several layers of lipids that are chemically “stapled” to one another, making the particles more durable inside the body.
“It’s like going from a soap bubble to a rubber tire. You have something that’s chemically much more resistant to disassembly,” Irvine says.
This allows the particles to resist disintegration once they reach the lungs. With this sturdier packaging, the protein vaccine remains in the lungs long enough for immune cells lining the surface of the lungs to grab them and deliver them to T cells. Activating T cells is a critical step for the immune system to form a memory of the vaccine particles so it will be primed to respond again during an infection.
Stopping the spread of infection
In studies of mice, the researchers found that HIV or cancer antigens encapsulated in nanoparticles were taken up by immune cells much more successfully than vaccine delivered to the lungs or under the skin without being trapped in nanoparticles.
HIV does not infect mice, so to test the immune response generated by the vaccines, the researchers infected the mice with a version of the vaccinia virus that was engineered to produce the HIV protein delivered by the vaccine.
Mice vaccinated with nanoparticles were able to quickly contain the virus and prevent it from escaping the lungs. Vaccinia virus usually spreads to the ovaries soon after infection, but the researchers found that the vaccinia virus in the ovaries of mice vaccinated with nanoparticles was undetectable, while substantial viral concentrations were found in mice that received other forms of the vaccine.
Mice that received the nanoparticle vaccine lost a small amount of weight after infection but then fully recovered, whereas the viral challenge was 100 percent lethal to mice who received the non-nanoparticle vaccine.
“Giving the vaccine at the mucosal surface in the nanocapsule form allowed us to completely block that systemic infection,” Irvine says.
The Latest Bing News on:
Nanoparticle vaccine
- N4 Pharma and SRI to Collaborate on Intracellular Delivery to Specific Target Cellson April 26, 2024 at 1:13 pm
N4 Pharma. N4 Pharma Announces Collaboration with SRI to Target and Treat Cells in the Human Body that Have Been Previously Unreachable. Press Release. Apr. 25, 2024.
- COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battleon April 26, 2024 at 11:45 am
Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfizer, BioNTech, and CureVac, as GSK joins the fray, alleging patent ...
- GSK Sues Pfizer and BioNTech Over Alleged COVID-19 Patent Infringementon April 26, 2024 at 7:29 am
With its lawsuit filed against Pfizer and BioNTech, the British multinational biopharma has joined the high-profile patent battle over mRNA technology used in COVID-19 vaccines.
- Acuitas, CureVac settle lawsuit over COVID-19 vaccine patent rightson April 25, 2024 at 2:27 pm
Biotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas' lawsuit demanding credit for inventions related to COVID-19 vaccines, according to a filing on Thursday in Virginia ...
- Cows' milk particles used for effective oral delivery of drugson April 24, 2024 at 11:16 am
Researchers have found that tiny particles present in cows' milk could offer, for the first time, an effective method for the oral delivery of RNA drugs.
- Moderna Investors Should Beware Patent-Dispute Fallouton April 23, 2024 at 11:40 am
Moderna's stock soared on positive cancer vaccine trial results, but legal troubles loom as a patent dispute threatens massive damages. Read my analysis here.
- Moderna gets grant for vaccine composition for varicella zoster viruson April 23, 2024 at 6:00 am
Discover how Moderna's groundbreaking patent for a nucleic acid vaccine targeting varicella zoster virus could revolutionize immunization. Learn about the innovative mRNA and lipid nanoparticle ...
- Engineering Powerful Vaccines with Lipid Nanotechnologyon April 21, 2024 at 6:15 am
In this, lipid nanoparticle (LNP) technology has emerged as highly promising. Progress in medical science has facilitated the seamless integration of lipid nanotechnology into standard therapy, ...
- New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruseson April 17, 2024 at 7:41 pm
Researchers at Georgia Tech and the University of Wisconsin have created a broad-spectrum vaccine capable of defending against various SARS-CoV-2 variants and related bat coronaviruses.
- Pfizer, BioNTech Get Legal Pause in Moderna’s COVID-19 Vaccine Patent Lawsuiton April 16, 2024 at 5:54 am
A federal court in Massachusetts has granted Pfizer and BioNTech’s motion to put on hold Moderna’s lawsuit over alleged patent infringement related to their COVID-19 vaccine Comirnaty.
The Latest Google Headlines on:
Nanoparticle vaccine
[google_news title=”” keyword=”Nanoparticle vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Mucosal vaccines
- New UTI vaccine wards off infection for years, early studies suggeston April 26, 2024 at 12:39 pm
More than 50% of the patients who used a new mouth-spray-based vaccine didn't have a UTI for up to nine years.
- Nature Publication Highlights the Benefits of Tropis® Intradermal When Used to Administer a First-in-Class Self-Amplifying mRNA Vaccineon April 24, 2024 at 7:10 am
Nature study shows delivery of a novel self-amplifying mRNA-based vaccine with Tropis directly into the dermis significantly boosts immune responses.
- Repurposed nasal antibiotic neomycin shows promise in preventing and treating respiratory viral infectionson April 23, 2024 at 11:16 pm
Intranasal administration of neomycin sulfate in murine models shows promise as a prophylactic and therapeutic agent against respiratory viruses like influenza A and SARS-CoV-2 by inducing ...
- COVID Shot Boosts Mucosal Immunity in Previously Infected Peopleon April 23, 2024 at 12:35 pm
COVID-19 mRNA vaccines stimulated mucosal immunity in people previously infected with SARS-CoV-2, but generated only a tiny amount of immunity in people who had never been infected, according to a ...
- Needle-Free Vaccines: Leading Innovation in Drug Deliveryon April 18, 2024 at 2:28 pm
Experts discuss alternative administration roots and why they matter. Megan Livingston, Vice President of Business Development, Jurata Thin Film Inc. Gunilla B. Jacobson, Director of Translational ...
- Rotavirus Still Ranks High as Cause of Acute Gastroenteritis in Childrenon April 18, 2024 at 9:30 am
Rotavirus may not be on the hot list of viruses dominating headlines, but globally, it still tops the charts as the leading cause of severe, dehydrating diarrhea in children younger than 5 years, ...
- Time names Yale professor as one of the 100 most influential people of 2024on April 17, 2024 at 9:13 am
NEW HAVEN, CT (WFSB) - A Yale University professor was listed as one of Time’s 100 most influential people of 2024. Akiko Iwasaki, Ph.D., is a sterling professor of Immunobiology and molecular, ...
- Study highlights how age affects nasal cell response to SARS-CoV-2on April 16, 2024 at 9:04 pm
Researchers reveal age-related differences in nasal epithelial cell responses to SARS-CoV-2, showing variations in cell types and viral dynamics across pediatric, adult, and older adult groups.
- Virologist offers perspective on avian influenza outbreakon April 16, 2024 at 9:20 am
Health officials around the globe, including the Centers for Disease Control and Prevention and the European Center for Disease Control and Prevention, are monitoring the ongoing avian influenza ...
- How to Avoid One of the Deadliest Forms of Skin Canceron April 15, 2024 at 6:52 pm
The ultraviolet rays in sunlight are a leading risk factor for skin cancer, which will affect one in five Americans over their lifetime. That includes melanoma, among the deadliest types. About ...
The Latest Google Headlines on:
Mucosal vaccines
[google_news title=”” keyword=”mucosal vaccines” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]